Atlas Trials

The GRK2 Inhibitor Paroxetine as a Novel Adjunct to Conventional Therapy in Rheumatoid Arthritis Patients

Clinical trial NCT04757571 · WITHDRAWN

Trial details

NCT number
NCT04757571
Sponsor
Sadat City University
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Rheumatoid Arthritis
Start date
2021-02-01
Primary completion
2024-12-31
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.